(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR For the transition period from to | --- | --- | |--------------------------------------------------------------------------------------------------|---------------------------------------------| | | | | Canopy Growth Corporation (Exact name of registrant as specified | in its charter) | | Canada | N/A | | (State or other jurisdiction of | (I.R.S. Employer | | i ...

Table of Contents As filed with the Securities and Exchange Commission on July 19, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANOPY GROWTH CORPORATION (Exact name of registrant as specified in its charter) Canada 2833 N/A (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial (I.R.S. Employer Identification Number) Classification Code Number) 1 Hershe ...

Canopy Growth Corporation (NASDAQ:CGC) Q4 2023 Results Conference Call June 22, 2023 5:30 PM ET Company Participants Tyler Burns - Director, IR David Klein - CEO Judy Hong - CFO Conference Call Participants Tamy Chen - BMO Capital Markets Vivien Azer - TD Cowen Aaron Grey - Alliance Global Partners John Zamparo - CIBC Capital Markets Michael Lavery - Piper Sandler Matt Bottomley - Canaccord Genuity Pablo Zuanic - Zuanic & Associates Doug Miehm - RBC Capital Markets Operator Good afternoon, ladies and gentle ...

| --- | --- | |----------------------------------------------------------|------------| | SECURITIES AND EXCHANGE Washington, D.C. 20549 | COMMISSION | | FORM 10-K | | Canopy Growth Corporation (Exact name of registrant as specified in its charter) Canada (State or other jurisdiction of incorporation or organization) 1 Hershey Drive Smiths Falls, Ontario K7A 0A8 | --- | --- | --- | |---------|----------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (I.R.S. | Empl ...

Canopy Growth Corporation (NASDAQ:CGC) Q3 2023 Earnings Conference Call February 9, 2023 10:00 AM ET Company Participants Tyler Burns - Director, IR David Klein - CEO Judy Hong - CFO Conference Call Participants Tamy Chen - BMO Capital Markets Victor Ma - Cowen & Company Chris Carey - Wells Fargo John Zamparo - CIBC Nadine Sarwat - Bernstein Andrew Carter - Stifel Matthew Baker - Cantor Fitzgerald Doug Miehm - RBC Capital Markets Aaron Grey - Alliance Global Partners Matt Bottomley - Canaccord Operator Good ...

Asset impairment and restructuring costs recorded in the nine months ended December 31, 2022 were primarily related to: The following table presents loss from equity method investments, other income (expense), net, and income tax (expense) recovery for the nine months ended December 31, 2022 and 2021: Other income (expense), net was an expense amount of $406.8 million in the nine months ended December 31, 2022, as compared to an income amount of $810.8 million in the nine months ended December 31, 2021. The ...

Financial Data and Key Metrics Changes - In Q2, the company generated net revenue of CAD 118 million, representing a 10% decline year-over-year, but a 7% sequential increase compared to Q1 [34][35] - Gross margins and adjusted EBITDA improved significantly year-over-year, driven by lower inventory charges and cost savings initiatives [36][47] - Free cash flow in Q2 was an outflow of CAD 135 million, with CAD 41 million in interest payments [56] Business Line Data and Key Metrics Changes - Canadian cannabis revenues declined 27% year-over-year but were stable sequentially; medical revenue grew 8% year-over-year [39][40] - BioSteel delivered record revenues of nearly CAD 30 million, with year-over-year growth of 299% and sequential growth of 67% [21][43] - Storz & Bickel revenues decreased 7% year-over-year, but gross margins increased to 44% from 37% [44][46] Market Data and Key Metrics Changes - In Canada, adult-use B2B premium and mainstream sales accounted for 58% of sales, up from 56% last year [12] - BioSteel's share of isotonic beverage sales in Ontario reached 11.2%, representing an increase of 630 basis points year-over-year [23] - The Rest of World Cannabis segment saw a modest decline year-over-year, with strong growth in Australia offset by declines in the US CBD business [42] Company Strategy and Development Direction - The company is focused on fast-tracking entry into the US cannabis market through Canopy USA, which is expected to enhance growth and profitability [29][31] - The divestiture of Canadian retail operations aims to reduce channel conflict and improve distribution [20][53] - The company is committed to achieving profitability in Canada while investing in high-potential opportunities like BioSteel [67] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges posed by labor disruptions and supply chain issues but expressed optimism about the company's strategic direction and market opportunities [10][36] - The company expects continued year-over-year growth from BioSteel and improvements in the Canadian adult-use B2B business [60][61] - Management anticipates that Canopy USA will significantly improve growth and profitability once the acquisitions close [66] Other Important Information - The company has entered into an agreement to tender approximately CAD 187.5 million of outstanding term loans at a discounted price [57] - The acquisition of a manufacturing facility in Virginia is expected to support BioSteel's growth strategy and improve margins [26][51] Q&A Session Summary Question: What is the plan for entering the US market? - The company plans to hold a shareholder vote to approve the creation of exchangeable shares in early 2023, followed by the acquisition of Acreage, Jetty, and Wana [69][70] Question: What is the plan if NASDAQ denies the pending acquisition? - The company is in constructive dialogue with NASDAQ and does not foresee imminent risks to its listing; there are multiple paths to address NASDAQ's concerns [71][72] Question: Can you explain the strategy for BioSteel's in-house manufacturing? - The acquisition of the Verona facility ensures supply and is expected to improve margins by eliminating co-packing costs [75][76] Question: What is the outlook for the Canadian cannabis business? - The company is focused on optimizing its portfolio and achieving profitability while navigating challenges in the market [96][101] Question: Will Canopy USA's assets be accessible to Canopy Growth shareholders? - The visibility of Canopy USA's performance and the streamlining of resources are expected to benefit Canopy Growth shareholders [109][111]

CANOPY GROWTH Q2 FY2023 EARNINGS PRESENTATION November 9, 2022 DISCLAIMERS AND CAUTIONARY STATEMENTS 2 Forward-Looking Information This presentation contains "forward-looking statements" and "forward-looking information" within the meaning of applicable U.S. and Canadian securities laws (collectively, "forward-looking statements") which involve certain known and unknown risks and uncertainties which may cause the actual results, performance or achievements of Canopy Growth Corporation ("Canopy Growth" or th ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38496 Canopy Growth Corporation (Exact name of registrant as specified in its charter) Canada N/A ( State or other jurisdicti ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each classTrading Symbol(s) Name of each exchange on which registered Common shares, no par value CGC NASDAQ Global Select Market FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Num ...